COPD and inhaler devices
... has a narrow therapeutic range, potential for drug interactions, and requires concentration monitoring. In Australia, low doses are sometimes used in patients who still remain symptomatic despite optimal inhaled therapy. There is little published evidence to support dosing in this context; seek spec ...
... has a narrow therapeutic range, potential for drug interactions, and requires concentration monitoring. In Australia, low doses are sometimes used in patients who still remain symptomatic despite optimal inhaled therapy. There is little published evidence to support dosing in this context; seek spec ...
Treatment
... headache, abdominal pain, abdominal distension, and gas for patients treated for CIC; nausea and diarrhea for patients treated for Opioid-Induced Constipation. The most common side effects of taking AMITIZA (8 mcg) twice daily for IBS-C are nausea, diarrhea, and abdominal pain. These are not all the ...
... headache, abdominal pain, abdominal distension, and gas for patients treated for CIC; nausea and diarrhea for patients treated for Opioid-Induced Constipation. The most common side effects of taking AMITIZA (8 mcg) twice daily for IBS-C are nausea, diarrhea, and abdominal pain. These are not all the ...
Exelon (rivastigmine)
... (12 mg/day). The dosage should be adjusted only after a minimum of 2 weeks at the lower dosage. The maximum dosage is 12 mg/day. ...
... (12 mg/day). The dosage should be adjusted only after a minimum of 2 weeks at the lower dosage. The maximum dosage is 12 mg/day. ...
ADHD Medication Guidelines
... Treatment includes medical management, behavior modification, counseling, and school or work accommodations. The medications charted above include: (1) stimulants, (2) non-stimulant Strattera (atomoxetine) with effects similar to stimulants, (3) antidepressant Wellbutrin (bupropion) and (4) two anti ...
... Treatment includes medical management, behavior modification, counseling, and school or work accommodations. The medications charted above include: (1) stimulants, (2) non-stimulant Strattera (atomoxetine) with effects similar to stimulants, (3) antidepressant Wellbutrin (bupropion) and (4) two anti ...
Product Information for Dexamethasone
... Pty Ltd PM-2014-00332-1-5 Final 25 October 2016. This Product Information was approved at the time this AusPAR was published. ...
... Pty Ltd PM-2014-00332-1-5 Final 25 October 2016. This Product Information was approved at the time this AusPAR was published. ...
Penicillins
... Binding to -lactamases and inactivate them, thus preventing the destruction of -lactam antibiotics which are substrates for -lactamases. They are most active against plasmid-encoded beta-lactamases such as those produced by gonococci, streptococci, E coli, and H influenzae. They are not good inhi ...
... Binding to -lactamases and inactivate them, thus preventing the destruction of -lactam antibiotics which are substrates for -lactamases. They are most active against plasmid-encoded beta-lactamases such as those produced by gonococci, streptococci, E coli, and H influenzae. They are not good inhi ...
File - Developing Anaesthesia
... Rivaroxaban is classified as a Class C drug with respect to pregnancy. Class C drugs are those drugs which, owing to their pharmacological effects, have caused or may be suspected of causing, harmful effects on the human fetus or neonate without causing malformations. These effects may be reversible ...
... Rivaroxaban is classified as a Class C drug with respect to pregnancy. Class C drugs are those drugs which, owing to their pharmacological effects, have caused or may be suspected of causing, harmful effects on the human fetus or neonate without causing malformations. These effects may be reversible ...
(PowerPoint)
... Off-label Discussion Disclosure This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. PCME does not recommend the use of any agent outside of the labeled indications. Please refer to the officia ...
... Off-label Discussion Disclosure This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. PCME does not recommend the use of any agent outside of the labeled indications. Please refer to the officia ...
SELEGILINE
... reservoir of drug in each patch, multiday administration from a single patch is generally not recommended and has not been tested; because of residual drug in the patch after 24 hours of administration, discard used patches in a manner that prevents accidental application or ingestion by children, p ...
... reservoir of drug in each patch, multiday administration from a single patch is generally not recommended and has not been tested; because of residual drug in the patch after 24 hours of administration, discard used patches in a manner that prevents accidental application or ingestion by children, p ...
Triple abx vs bactrim
... sulfonamides = bactrim/septra (tmp/smx) The most important thing you should know about antibiotics! Never expect a doctor to phone-in a prescription for an antibiotic without seeing you first. Epididymitis (inflammation of the epididymis; see the image below) is a significant cause of morbidity and ...
... sulfonamides = bactrim/septra (tmp/smx) The most important thing you should know about antibiotics! Never expect a doctor to phone-in a prescription for an antibiotic without seeing you first. Epididymitis (inflammation of the epididymis; see the image below) is a significant cause of morbidity and ...
PID comments (clarifax in January 2006) - Bristol
... On-treatment value worsened from baseline to Grade 3 or Grade 4 for all parameters except albumin (any on treatment value <2.5 g/dL), confirmed creatinine increase ≥ 44.2 mmol/L and ALT >10 X ULN and >2 X baseline. Studies AI463022 and AI463027. . Mean duration of therapy was 69 weeks for BARACLUDE- ...
... On-treatment value worsened from baseline to Grade 3 or Grade 4 for all parameters except albumin (any on treatment value <2.5 g/dL), confirmed creatinine increase ≥ 44.2 mmol/L and ALT >10 X ULN and >2 X baseline. Studies AI463022 and AI463027. . Mean duration of therapy was 69 weeks for BARACLUDE- ...
Guidelines for predicting toxic doses of pharmaceuticals
... 10 mg Olanzapine in a 17kg produced pronounced CNS depression. This amount is about 0.6mg/kg and is obviously well above the MTD (NPIS London). ...
... 10 mg Olanzapine in a 17kg produced pronounced CNS depression. This amount is about 0.6mg/kg and is obviously well above the MTD (NPIS London). ...
الشريحة 1
... drugs such as methotrexate and gold—they alter the course of an arthritic disorder. Several NSAIDs (including aspirin) appear to reduce the incidence of colon cancer when taken chronically. Several large epidemiologic studies have shown a 50% reduction in relative risk when the drugs are taken for 5 ...
... drugs such as methotrexate and gold—they alter the course of an arthritic disorder. Several NSAIDs (including aspirin) appear to reduce the incidence of colon cancer when taken chronically. Several large epidemiologic studies have shown a 50% reduction in relative risk when the drugs are taken for 5 ...
Xenazine® (tetrabenazine) Treatment Form
... essential to concurrent therapy. • XENAZINE can also cause other serious side effects, including: akathisia, restlessness, agitation, parkinsonism, and sedation/ somnolence. These side effects may require a dose reduction or discontinuation of XENAZINE. Monitoring of vital signs on standing should b ...
... essential to concurrent therapy. • XENAZINE can also cause other serious side effects, including: akathisia, restlessness, agitation, parkinsonism, and sedation/ somnolence. These side effects may require a dose reduction or discontinuation of XENAZINE. Monitoring of vital signs on standing should b ...
generalized tonic
... irregular teeth • rarely used in the treatment of epilepsy and should certainly be discontinued during pregnancy ...
... irregular teeth • rarely used in the treatment of epilepsy and should certainly be discontinued during pregnancy ...
Tables Final-3-5
... treatment of uncomplicated urinary tract infections. In Europe intravenous formulations are available. Outside the United States, IV fosfomycin has been used for a wide range of infections including bacteremia, osteomyelitis, and meningitis at daily doses of 1–16 g divided in three or four doses. G ...
... treatment of uncomplicated urinary tract infections. In Europe intravenous formulations are available. Outside the United States, IV fosfomycin has been used for a wide range of infections including bacteremia, osteomyelitis, and meningitis at daily doses of 1–16 g divided in three or four doses. G ...
Review: Side Effects of Some Commonly Used Allergy Medications
... DOI: 10.23937/2572-3308.1510024 ...
... DOI: 10.23937/2572-3308.1510024 ...
MEDROL PRESENTATION Methylprednisolone (4 mg or 100 mg) tablets
... close observation is necessary as reactivation of the disease may occur. During prolonged corticosteroid therapy, these patients should receive chemoprophylaxis. Kaposi's sarcoma has been reported to occur in patients receiving corticosteroid therapy. Discontinuation of corticosteroids may result in ...
... close observation is necessary as reactivation of the disease may occur. During prolonged corticosteroid therapy, these patients should receive chemoprophylaxis. Kaposi's sarcoma has been reported to occur in patients receiving corticosteroid therapy. Discontinuation of corticosteroids may result in ...
Modecate® Concentrate - Bristol
... Prolongation of the QT interval As with other neuroleptics, very rare cases of QT interval prolongation have been reported with MODECATE. Neuroleptic phenothiazines may potentiate QT interval prolongation, which increases the risk of onset of serious ventricular arrhythmias of the torsade de pointes ...
... Prolongation of the QT interval As with other neuroleptics, very rare cases of QT interval prolongation have been reported with MODECATE. Neuroleptic phenothiazines may potentiate QT interval prolongation, which increases the risk of onset of serious ventricular arrhythmias of the torsade de pointes ...
pioglitazone
... acarbose doses greater than 50 mg three times daily provided no additional glycemic benefit, but were associated with more side effects ...
... acarbose doses greater than 50 mg three times daily provided no additional glycemic benefit, but were associated with more side effects ...
Initiating Depot Antipsychotics
... The strategy for initiating a depot drug will vary depending upon factors such as prior drug dosage and clinical state. Some recommend initial loading dose, some a more gradual titration. The need to supplement with oral medication should be considered particularly in the first 4 to 6 weeks. Abrupt ...
... The strategy for initiating a depot drug will vary depending upon factors such as prior drug dosage and clinical state. Some recommend initial loading dose, some a more gradual titration. The need to supplement with oral medication should be considered particularly in the first 4 to 6 weeks. Abrupt ...
a comparative study between palonosetron and granisetron to
... KEYWORDS: Palonosetron, Granisetron, Postoperative Nausea and Vomiting (PONV), Middle ear surgery. INTRODUCTION: Post-operative nausea and vomiting (PONV) are frequent and unpleasant symptoms following general anaesthesia. Some patients view PONV as being more debilitating than operative procedure i ...
... KEYWORDS: Palonosetron, Granisetron, Postoperative Nausea and Vomiting (PONV), Middle ear surgery. INTRODUCTION: Post-operative nausea and vomiting (PONV) are frequent and unpleasant symptoms following general anaesthesia. Some patients view PONV as being more debilitating than operative procedure i ...
Cetrotide® 0.25 mg (cetrorelix acetate for injection)
... When administered to rats for the first seven days of pregnancy, cetrorelix acetate did not affect the development of the implanted conceptus at doses up to 38 μg/kg (approximately 1 times the recommended human therapeutic dose based on body surface area). However, a dose of 139 μg/kg (approximately ...
... When administered to rats for the first seven days of pregnancy, cetrorelix acetate did not affect the development of the implanted conceptus at doses up to 38 μg/kg (approximately 1 times the recommended human therapeutic dose based on body surface area). However, a dose of 139 μg/kg (approximately ...
Bascom Palmer Files - Utah Optometric Association
... • The 1st safe, broad-spectrum ophthalmic antibiotics • 1st released for ophthalmic use in early 1990’s • Represented an important break-through for clinicians • For the 1st time strong commercially available antibiotics available to treat bacterial conjunctivitis and ulcerative keratitis • Broad sp ...
... • The 1st safe, broad-spectrum ophthalmic antibiotics • 1st released for ophthalmic use in early 1990’s • Represented an important break-through for clinicians • For the 1st time strong commercially available antibiotics available to treat bacterial conjunctivitis and ulcerative keratitis • Broad sp ...
PROSOGAN® INJECTION Lansoprazole
... Since physiological function is generally decreased in elderly patients, PROSOGAN ® Injection 30 mg should be carefully administered. Use during Pregnancy, Delivery or Lactation 1. PROSOGAN ® Injection 30 mg should be used in pregnant women or women having possibilities of being pregnant only if the ...
... Since physiological function is generally decreased in elderly patients, PROSOGAN ® Injection 30 mg should be carefully administered. Use during Pregnancy, Delivery or Lactation 1. PROSOGAN ® Injection 30 mg should be used in pregnant women or women having possibilities of being pregnant only if the ...
Ofloxacin
Ofloxacin is a synthetic antibiotic of the fluoroquinolone drug class considered to be a second-generation fluoroquinolone.Ofloxacin was first patented in 1982 (European Patent Daiichi) and received approval from the U.S. Food and Drug Administration (FDA) on December 28, 1990. Ofloxacin is sold under a wide variety of brand names as well as generic drug equivalents, for oral and intravenous administration. Ofloxacin is also available for topical use, as eye drops and ear drops (marketed as Ocuflox and Floxin Otic respectively in the United States and marketed as Optiflox, eylox respectively in Jordan and Saudi Arabia).Ofloxacin is a racemic mixture, which consists of 50% levofloxacin (the biologically active component) and 50% of its “mirror image” or enantiomer dextrofloxacin.Ofloxacin has been associated with adverse drug reactions, such as tendon damage (including spontaneous tendon ruptures) and peripheral neuropathy (which may be irreversible); tendon damage may manifest long after therapy had been completed, and, in severe cases, may result in lifelong disabilities.